Browse our materials
for additional information

The following is a searchable and filterable list of our news posts, press releases, white papers, articles, scientific posters, and much more.
If you can’t find something, please let us know and we’ll reach out to you as soon as we can.

Filter your resources:
  • Rewiring Drug Research and Development through Human Data-Driven Discovery (HD3)

    Jackson, D.B. et al. Pharmaceutics 2023, 15(6), 1673
    Open resource
  • Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms

    Brock, S. et al. Front. Mol. Med. 2023, 2:1035290.
    Open resource
  • Daten töten. Den Krebs.

    An article by Friedrich von Bohlen in FOCUS Die Welt in 2023 (in German)
    Download article
  • Molecular Health and collaborators prove new analytical approach that leverages real-world data to anticipate molecular causation of adverse drug reactions

    Press release, 10 March 2022
    Read more
  • Advancing drug safety science by integrating molecular knowledge with post‐marketing adverse event reports

    Soldatos, T. G. et al. CPT Pharmacometrics Syst Pharmacol. 2022 May;11(5):540-555. doi: 10.1002/psp4.12765
    Open resource
  • Application of a patient-centered reverse translational systems-based approach to understand mechanisms of an adverse drug reaction of immune checkpoint inhibitors

    Kim, S. et al. Clin Transl Sci. 2022 Jun;15(6):1430-1438. doi: 10.1111/cts.13254
    Open resource
  • The COVID-19 explorer – An integrated, whole patient knowledge model of COVID-19 disease

    Brock, S. et al. Front. Mol. Med. 2022, 2:1035215.
    Open resource
  • Molecular Health and Essen University Hospital launch collaborative project to improve care for COVID-19 patients

    Press release, 9 August 2021
    Read more
  • Wir bringen die biologische Grammatik in die Medizin

    Plattform Life Sciences “Smarte Medizin” – Interview with Friedrich von Bohlen (in German)
    Open resource
  • Target adverse event profiles for predictive safety in the postmarket setting

    Peter Schotland, Rebecca Racz, David B. Jackson, Theodoros G. Soldatos, Robert Levin, David G. Strauss and Keith Burkhart. Clinical Pharmacology & Therapeutics Volume 109, Issue 5, Pages: 1159-1362 (May 2021)
    Open resource
  • Molecular Health – intelligent solutions for smarter healthcare

    NATURE BiopharmaDealmakers
    Open resource
  • Datenprojekt zu Covid-Langzeitfolgen startet

    Handelsblatt (in German)
    Open resource
  • Wie der MH Corona Explorer die Versorgung COVID-19-Kranker verbessern soll

    ÄrzteZeitung (in German)
    Open resource
  • A case study of a patient-centered reverse translational systems-based approach to understand adverse event profiles in drug development

    Kim, S. et al. Clin Transl Sci . 2022 Apr;15(4):1003-1013. doi: 10.1111/cts.13219
    Open resource
GDPR Cookie Consent with Real Cookie Banner